Moors & Cabot’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$200K Sell
8,139
-451
-5% -$10.4K 0.01% 900
2026
Q1
$206K Buy
+8,590
New +$210K 0.01% 853
2025
Q4
Sell
-10,250
Closed -$206K 935
2025
Q3
$206K Buy
+10,250
New +$172K 0.01% 829
2023
Q4
Sell
-16,650
Closed -$187K 862
2023
Q3
$187K Buy
16,650
+3,900
+31% +$45.3K 0.01% 759
2023
Q2
$128K Sell
12,750
-9,233
-42% -$85.7K 0.01% 785
2023
Q1
$207K Sell
21,983
-1,292
-6% -$15.2K 0.01% 746
2022
Q4
$284K Sell
23,275
-5,950
-20% -$74.2K 0.02% 606
2022
Q3
$363K Sell
29,225
-1,542
-5% -$27K 0.03% 501
2022
Q2
$604K Buy
30,767
+125
+0.4% +$2.96K 0.04% 368
2022
Q1
$799K Sell
30,642
-225
-0.7% -$5.99K 0.05% 346
2021
Q4
$876K Buy
30,867
+275
+0.9% +$8.55K 0.05% 315
2021
Q3
$977K Buy
30,592
+4,500
+17% +$151K 0.06% 287
2021
Q2
$905K Buy
26,092
+3,900
+18% +$129K 0.06% 278
2021
Q1
$656K Buy
22,192
+745
+3% +$22.9K 0.05% 333
2020
Q4
$658K Buy
21,447
+1,830
+9% +$55.8K 0.06% 295
2020
Q3
$548K Buy
19,617
+589
+3% +$14.9K 0.05% 314
2020
Q2
$403K Buy
19,028
+6,378
+50% +$141K 0.04% 366
2020
Q1
$281K Sell
12,650
-5,850
-32% -$160K 0.04% 391
2019
Q4
$544K Buy
18,500
+6,450
+54% +$175K 0.05% 323
2019
Q3
$323K Buy
+12,050
New +$362K 0.04% 425

Other funds holding ELAN

Moors & Cabot's ELAN Position: Q2 2026 in Review

Moors & Cabot reduced its Elanco Animal Health (ELAN) stake by 5.3% in Q2 2026, selling an estimated $10.4K and leaving 8,139 shares worth $200K. The position accounts for 0.01% of the portfolio, ranked #900.

Moors & Cabot first reported a position in ELAN in Q3 2019 and has held it in 20 quarters since. The position peaked at $977K in Q3 2021. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Moors & Cabot held 8,139 shares of Elanco Animal Health worth $200K as of Q2 2026.
  • Moors & Cabot sold 451 Elanco Animal Health shares in Q2 2026, an estimated $10.4K.
  • Elanco Animal Health made up 0.01% of Moors & Cabot's portfolio in Q2 2026, its #900 holding.
  • Moors & Cabot first reported a position in Elanco Animal Health in Q3 2019 and has held it in 20 quarters since.
  • Moors & Cabot's Elanco Animal Health position peaked at $977K in Q3 2021.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.